// App-Quantinova.ai

: Dissecting the genomic landscape of metastatic bladder cancer using circulating tumor DNA.

Researchers

Presenter

  • Werner J. Struss

Principal Investigators

  • Gillian Vandekerkhove

  • Matti Annala

  • Tilman Todenhoefer

  • Kevin Beja

  • Bernhard J. Eigl

  • Alexander William Wyatt

  • Peter C. Black

Medical Centers

  • Vancouver Prostate Centre and Department of Urologic Sciences, Vancouver, BC, Canada

  • Vancouver Prostate Centre, Vancouver, BC, Canada

  • Institute of Biosciences and Medical Technology, Tampere, Finland

  • Department of Dermatology Eberhard-Karls University of Tuebingen, Tuebingen, Germany

  • Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada

  • BC Cancer Agency, Vancouver, BC, Canada

  • Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada

  • The University of British Columbia, Vancouver, BC, Canada

Locations

  • Canada

  • Finland

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • AKT Serine

  • BRCA1-associated protein 1

  • Peripheral blood mononuclear cell

  • Peroxisome proliferator-activated receptor gamma

  • Phosphatase and tensin homolog

  • Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform

  • Cyclin D1

  • Cyclin Dependent Kinase Inhibitor 2A

  • Retinoblastoma protein

  • Epidermal growth factor receptor

  • erb-b2 receptor tyrosine kinase 2

  • Fibroblast growth factor receptor 3

  • Tumor protein p53

  • Xeroderma pigmentosum group D

  • Ataxia-telangiectasia mutated

  • Plasma cell-free DNA

Drug/Treatment

  • TP53

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved